SCHEMBL29930557

SCHEMBL29930557

COC(=O)[C@@H]1C[C@H](N(Cc2ccc(OC)cc2)C(=O)OC(C)(C)C)CN1Cc1ccccc1Cl

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPFFR1 Q9GZQ6 2/20 0.50
NPFFR2 Q9Y5X5 2/20 0.50
UBE2M P61081 1/20 0.43
DCUN1D1 Q96GG9 1/20 0.43
CXCR4 P61073 1/20 0.41
HSD11B1 P28845 1/20 0.40
CYP3A4 P08684 1/20 0.40
SLC16A3 O15427 1/20 0.39
SLC16A1 P53985 1/20 0.39
NR1H4 Q96RI1 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
TAS2R14 Q9NYV8 1/20 0.38
ALDH1A1 P00352 1/20 0.37
SHH Q15465 1/20 0.37
SMO Q99835 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28348073 0.92 NPFFR1 (0.45) NPFFR1NPFFR2UBE2MDCUN1D1CXCR4
SCHEMBL29930039 0.90 ATM (0.41) NPFFR1NPFFR2UBE2MDCUN1D1HSD11B1
SCHEMBL13841889 0.85 HSD11B1 (0.50) HSD11B1CYP3A4NR1H4OPRM1ALDH1A1
SCHEMBL2822792 0.85 HSD11B1 (0.50) HSD11B1CYP3A4NR1H4OPRM1ALDH1A1
SCHEMBL28348072 0.82 HSD11B1 (0.42) NPFFR1NPFFR2HSD11B1SLC16A3SLC16A1
SCHEMBL28345159 0.81 HSD11B1 (0.40) NPFFR1NPFFR2HSD11B1SLC16A3SLC16A1
SCHEMBL2824379 0.76 HSD11B1 (0.52) HSD11B1NR1H4OPRM1
SCHEMBL13841892 0.76 HSD11B1 (0.52) HSD11B1NR1H4OPRM1
SCHEMBL28345021 0.76 NPFFR1 (0.79) NPFFR1NPFFR2CXCR4CYP3A4SMN1; SMN2
SCHEMBL2818863 0.75 HTR2A (0.44) HSD11B1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12390446-B2 Proline-based neuropeptide FF receptor modulators RESEARCH TRIANGLE INSTITUTE (US) 2025-08-19 US disclosed
US-20240058303-A1 PROLINE-BASED NEUROPEPTIDE FF RECEPTOR MODULATORS RES TRIANGLE INST (US) 2024-02-22 US disclosed
US-11826350-B2 Proline-based neuropeptide FF receptor modulators RESEARCH TRIANGLE INSTITUTE (US) 2023-11-28 US disclosed
US-20230091922-A1 PROLINE-BASED NEUROPEPTIDE FF RECEPTOR MODULATORS RES TRIANGLE INST (US) 2023-03-23 US disclosed
US-11491136-B2 Proline-based neuropeptide FF receptor modulators RESEARCH TRIANGLE INSTITUTE (US) 2022-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11491136-B2 Proline-based neuropeptide FF receptor modulators NPFFR1, NPFFR2, NPBWR1 NPFFR1 1/4885NPFFR2 2/4885UBE2M 4704/4885
US-12390446-B2 Proline-based neuropeptide FF receptor modulators NPFFR1, NPFFR2, NPBWR1 NPFFR1 1/4885NPFFR2 2/4885UBE2M 4704/4885
US-11826350-B2 Proline-based neuropeptide FF receptor modulators NPFFR1, NPFFR2, NPBWR1 NPFFR1 1/4885NPFFR2 2/4885UBE2M 4704/4885
US-20240058303-A1 PROLINE-BASED NEUROPEPTIDE FF RECEPTOR MODULATORS NPFFR1, NPFFR2, NPBWR1 NPFFR1 1/4885NPFFR2 2/4885UBE2M 4704/4885
US-20230091922-A1 PROLINE-BASED NEUROPEPTIDE FF RECEPTOR MODULATORS NPFFR1, NPFFR2, NPBWR1 NPFFR1 1/4885NPFFR2 2/4885UBE2M 4704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.